Needham & Company Maintains Bullish View on Sarepta Therapeutic (SRPT) Following Results and Eteplirsen Regulatory Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/25/2026

1. MU
2. QCOM
3. SPY
4. ICLR
5. JPM
6. USO
7. FUL
8. LAES

Go back to Needham & Company Maintains Bullish View on Sarepta Therapeutic (SRPT) Following Results and Eteplirsen Regulatory Update
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 16.02 -0.67 (4.01%)
Previous Close $16.69    52 Week High $63.73 
Open $16.73    52 Week Low $8.00 
Day High $16.85    P/E N/A 
Day Low $15.94    EPS $-5.69 
Volume 2,541,690